Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01643382 · ClinicalTrials.gov registry record · NA
Hyperglycemia in Renal Transplantation
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT01643382 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 60 participants.
The verdict
NCT01643382, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Based on multiple prior studies, kidney transplant recipients with diabetes are at higher risk for poor initial graft function after transplant. Our study is designed to determine if tight blood sugar control around the time of kidney transplant will improve short term graft function.
Interventions
- DRUG Insulin
- DRUG Insulin, Asp(B28)-
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-08 |
| Est. Completion | 2014-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01643382
The ClinicalTrials.gov registry entry for NCT01643382 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Insulin is the first listed.
NCT01643382 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01643382 about?
NCT01643382 is a clinical study titled "Hyperglycemia in Renal Transplantation". Based on multiple prior studies, kidney transplant recipients with diabetes are at higher risk for poor initial graft function after transplant. Our study is designed to determine if tight blood sugar control around the time of kidney transplant will improve short term graft function.
What is the current status of trial NCT01643382?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2012-08. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01643382?
The interventions under investigation include: Insulin (DRUG), Insulin, Asp(B28)- (DRUG).
Who is sponsoring clinical trial NCT01643382?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.